A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function

Clinical trial NCT07426380 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07426380
Sponsor: Eli Lilly and Company
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Kidney Disease Renal Insufficiency Chronic Kidney Failure, Chronic Renal Impairment Renal Insufficiency End Stage Kidney Disease

Start date: 2026-02-24
Primary completion: 2026-10-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.